2021 Annual Meeting

Virtual Meeting

The Society has made the difficult but necessary decision to host the 2021 Annual Meeting in a virtual only format due to uncertainty surrounding COVID-19 and the ability to travel internationally this year.

We look forward to providing you with an engaging online experience.

Click here for more information.

Registration Grants for Patient Advocacy Groups & Developing Country Scientists

Grant funding is available for a limited number of registrants from patient advocacy groups and researchers/scientists from developing countries. To apply for a grant please contact us at info@oligotherapeutics.org with the flowing information:

Full Name / title / organization/ project or position / brief description of your desire to attend

Organizing Committee

Co-Chairs:

• Daniel O’Reilly, PhD, RNA Therapeutics Institute, UMass Medical School
• Ronald Buijsen, PhD, Leiden University Medical Center
• Joseph Ochaba, PhD, Ionis Pharmaceuticals
• Erin M. McConnell, PhD, University of Ottawa

Committee Members:

• Annemieke Aartsma-Rus, PhD, Leiden University Medical Center
• Leonora Abdullahu, McGill University
• Shalini Anderson, PhD, AstraZeneca
• Annabelle Biscans, PhD, AstraZeneca
• David Corey, PhD, UT Southwestern
• Masad J. Damha, PhD, FCIC, McGill University
• Keith Gagnon, PhD, Southern Illinois University
• Bruno Godinho, PhD, Atalanta Therapeutics
• Holly Kordasiewicz, PhD, Ionis Pharmaceuticals
• Aurélie Lacroix, PhD, Sixfold Biosciences
• Marc Lemaitre, PhD, ML_Consult
• Martin Maier, PhD, Alnylam Pharmaceuticals
• John Maraganore, PhD, Alnylam Pharmaceuticals
• Mano Manoharan, PhD, Alnylam Pharmaceuticals
• Jimmy Weterings, PhD, AstraZeneca
• Tim Yu, PhD, Boston Children’s Hospital, Harvard University